Inhibrx Inc. Gains 47.47%
Tue, Oct 04, 2022 at 07:57 PM
Inhibrx Inc. (INBX:NASDAQ) soared at $29.76, a gain of 47.5%. On Tue, Oct 04, 2022, INBX:NASDAQ touched a New 2-Week High of $29.76. The stock got featured on our News Catalysts scanner on Tue, Oct 04, 2022 at 03:47 PM in the 'BIOTECH' category. From Tue, Sep 20, 2022, the stock recorded 80.00% Up Days and 72.73% Green Days
About Inhibrx Inc. (INBX:NASDAQ)
Inhibrx Inc is a clinical-stage biotechnology company focused on developing a pipeline of novel biologic therapeutic candidates.
Top 10 Gainers:
- Bit Brother Limited (BTB:NASDAQ), 185.46%
- Senti Biosciences Inc Com (SNTI:NASDAQ), 105.6%
- AeroClean Technologies Inc. (AERC:NASDAQ), 85.05%
- Pineapple Holdings Inc Com (PEGY:NASDAQ), 79.69%
- Top Ships Inc. (TOPS:NASDAQ), 67.08%
- Connexa Sports Technologies Inc. (CNXA:NASDAQ), 62.01%
- Inhibrx Inc. (INBX:NASDAQ), 47.47%
- First Eagle Alternative Capital BDC Inc. (FCRD:NASDAQ), 40.96%
- Sonendo Inc. (SONX:NYSE), 36.94%
- Value Line, Inc. (VALU:NASDAQ), 35.8%